Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 117

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 15
Chunk 117
---
     
    001-14895
     
    10.5
     
    9/19/22

     10.23
     
    Base Call Option Transaction Confirmation, dated as of September 13, 2022, between Sarepta Therapeutics, Inc. and Morgan Stanley & Co. LLC.
     
    8-K
     
    001-14895
     
    10.6
     
    9/19/22

     10.24  
     
    Base Call Option Transaction Confirmation, dated as of September 13, 2022, between Sarepta Therapeutics, Inc. and RBC Capital Markets, LLC.
     
    8-K
     
    001-14895
     
    10.7
     
    9/19/22

     10.25
     
    Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and Barclays Bank PLC.
     
    8-K
     
    001-14895
     
    10.8
     
    9/19/22

     10.26
     
    Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC.
     
    8-K
     
    001-14895
     
    10.9
     
    9/19/22

     10.27
     
    Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and Mizuho Markets Americas LLC.
     
    8-K
     
    001-14895
     
    10.10
     
    9/19/22

     10.28
     
    Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and Morgan Stanley & Co. LLC.
     
    8-K
     
    001-14895
     
    10.11
     
    9/19/22

     10.29
     
    Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Ther